302 related articles for article (PubMed ID: 23627736)
1. Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.
Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):379-87. PubMed ID: 23627736
[TBL] [Abstract][Full Text] [Related]
2. Dihydrofolate reductase inhibitors as antibacterial agents.
Hawser S; Lociuro S; Islam K
Biochem Pharmacol; 2006 Mar; 71(7):941-8. PubMed ID: 16359642
[TBL] [Abstract][Full Text] [Related]
3. Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening.
Wyss PC; Gerber P; Hartman PG; Hubschwerlen C; Locher H; Marty HP; Stahl M
J Med Chem; 2003 Jun; 46(12):2304-12. PubMed ID: 12773035
[TBL] [Abstract][Full Text] [Related]
4. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules.
Singh S; Supuran CT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):449-55. PubMed ID: 23808803
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs.
Iliades P; Meshnick SR; Macreadie IG
Antimicrob Agents Chemother; 2005 Feb; 49(2):741-8. PubMed ID: 15673759
[TBL] [Abstract][Full Text] [Related]
7. Structure-based drug discovery of carbonic anhydrase inhibitors.
Supuran CT
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):759-72. PubMed ID: 22468747
[TBL] [Abstract][Full Text] [Related]
8. Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase.
Bastien D; Ebert MC; Forge D; Toulouse J; Kadnikova N; Perron F; Mayence A; Huang TL; Vanden Eynde JJ; Pelletier JN
J Med Chem; 2012 Apr; 55(7):3182-92. PubMed ID: 22424148
[TBL] [Abstract][Full Text] [Related]
9. Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates.
Schmitz FJ; Perdikouli M; Beeck A; Verhoef J; Fluit AC;
J Antimicrob Chemother; 2001 Dec; 48(6):935-6. PubMed ID: 11733486
[No Abstract] [Full Text] [Related]
10. New Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors.
Suling WJ; Seitz LE; Reynolds RC; Barrow WW
Antimicrob Agents Chemother; 2005 Nov; 49(11):4801-3. PubMed ID: 16251337
[TBL] [Abstract][Full Text] [Related]
11. Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp.
Thielking DM; Destefano MS; Cynamon MH; Yeo AE
Antimicrob Agents Chemother; 2003 Mar; 47(3):1174. PubMed ID: 12604567
[No Abstract] [Full Text] [Related]
12. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.
Carta F; Pothen B; Maresca A; Tiwari M; Singh V; Supuran CT
Chem Biol Drug Des; 2009 Aug; 74(2):196-202. PubMed ID: 19549076
[TBL] [Abstract][Full Text] [Related]
14. Brodimoprim, a new bacterial dihydrofolate reductase inhibitor: a minireview.
Periti P
J Chemother; 1995 Jun; 7(3):221-3. PubMed ID: 7562018
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
16. Toward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant
Reeve SM; Si D; Krucinska J; Yan Y; Viswanathan K; Wang S; Holt GT; Frenkel MS; Ojewole AA; Estrada A; Agabiti SS; Alverson JB; Gibson ND; Priestley ND; Wiemer AJ; Donald BR; Wright DL
ACS Infect Dis; 2019 Nov; 5(11):1896-1906. PubMed ID: 31565920
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
Rao GS; Kumar M
Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
[TBL] [Abstract][Full Text] [Related]
18. Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofolate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis, 3-way partial least-squares regression, and 3-way factor analysis.
Dunn WJ; Hopfinger AJ; Catana C; Duraiswami C
J Med Chem; 1996 Nov; 39(24):4825-32. PubMed ID: 8941396
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
20. Dihalogenated sulfanilamides and benzolamides are effective inhibitors of the three β-class carbonic anhydrases from Mycobacterium tuberculosis.
Maresca A; Scozzafava A; Vullo D; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):384-7. PubMed ID: 22214209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]